NEDC e-Bulletin Issue Five | November 2012 Editors Note: Welcome to the November issue of the NEDC e-Bulletin.
Read moreGlucagon-like peptide-1receptor agonists (GLP-1 RAs), such as semaglutide (Ozempic), are medications originally developed to treat type 2 diabetes.
Read more